Cutaneous infections from viral sources in solid organ transplant recipients

被引:1
|
作者
Miotto, Isadora Zago [1 ]
Neto, Cyro Festa [1 ]
de Oliveira, Walmar Roncalli Pereira [1 ]
机构
[1] Univ Sao Paulo, Med Sch, Dept Dermatol, Av Dr Eneas de Carvalho Aguiar 255, BR-05403900 Sao Paulo, Brazil
关键词
Viral infections; HPV; Herpesvirus; Kaposi 's sarcoma; Merkel cell carcinoma; IMMUNOSUPPRESSION; WARTS; MTOR; COMPLICATIONS; SIROLIMUS; CHILDREN; HISTORY; VIRUS;
D O I
10.1016/j.trim.2023.101838
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Solid organ transplant recipients (SOTRs) are susceptible to various dermatological complications caused by long-term immunosuppressive therapy. Of these complications, viral infections are noteworthy because of their high prevalence and the potential morbidity associated with viral carcinogenesis.Objectives: To evaluate the occurrence of cutaneous viral infections in SOTRs and their correlation with clinical features, transplant type, and the length and intensity of immunosuppressive therapy. Methods: This retrospective cohort study included SOTRs followed up at the Department of Dermatology in a tertiary hospital. The outcomes analyzed were the occurrence of cutaneous viral infections, including human papillomavirus (HPV) infection, herpes simplex, herpes zoster, molluscum contagiosum, Merkel cell carcinoma, Kaposi's sarcoma, and cytomegalovirus, and the occurrence of HPV-related neoplasms. Clinical variables, such as length and intensity of immunosuppression, type of transplanted organ, and comorbidities, were analyzed as possible risk factors for cutaneous viral infections in SOTRs.Results: A total of 528 SOTRs were included in this study, among which 53.8% had one or more viral infections. Of these, 10% developed a virus-associated malignancy (HPV-associated carcinoma, Merkel cell carcinoma, or Kaposi's sarcoma). The higher risk of viral infections among SOTRs was associated with cyclosporine intake (1.40-fold higher risk) and younger age at transplantation. The use of an immunosuppressive regimen, including additional drugs, was associated with a higher risk of genital HPV infection (1.50-fold higher risk for each in-cremental drug).Conclusions: The occurrence of cutaneous viral infections in SOTRs is directly associated with the duration and intensity of immunosuppressive therapy. Patients at higher risk were those taking drugs with a stronger impact on cellular immunity and/or those on an immunosuppressive regimen comprising various drugs.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Susceptibility of solid organ transplant recipients to viral pathogens with zoonotic potential: A mini-review
    Bezerra, Karine C.
    Vieira, Carlos Meton A. G.
    de Oliveira-Filho, Edmilson F.
    Reis, Christian Robson S.
    Oria, Reinaldo B.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2024, 28 (02)
  • [22] A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients
    Moghadamnia, Marjan
    Eshaghi, Hamid
    Alimadadi, Hosein
    Dashti-Khavidaki, Simin
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [23] Emerging viral infections in transplant recipients
    Kumar, D
    Humar, A
    CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (04) : 337 - 341
  • [24] Immunosuppressant-induced cutaneous drug reactions in solid organ transplant recipients
    Miotto, Isadora Zago
    de Castro e Souza, Bruno
    Tyring, Stephen K.
    de Oliveira, Walmar Roncalli Pereira
    TRANSPLANT IMMUNOLOGY, 2021, 64
  • [25] Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients
    Pascual, Julio
    Royuela, Ana
    Fernandez, Ana M.
    Herrero, Ignacio
    Delgado, Juan F.
    Sole, Amparo
    Guirado, Lluis
    Serrano, Trinidad
    de la Torre-Cisneros, Julian
    Moreno, Asuncion
    Cordero, Elisa
    Gallego, Roberto
    Lumbreras, Carlos
    Aguado, Jose M.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (06) : 819 - 831
  • [26] Human herpesvirus type 8 infections among solid organ transplant recipients
    Allen, UD
    PEDIATRIC TRANSPLANTATION, 2002, 6 (03) : 187 - 192
  • [27] Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
    Safdar, Nasia
    Smith, Jeannina
    Knasinski, Valerie
    Sherkow, Colleen
    Herrforth, Casey
    Knechtle, Stuart
    Andes, David
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 66 (01) : 7 - 15
  • [28] Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients
    Stelzmueller, Ingrid
    Lass-Floerl, Cornelia
    Geltner, Christian
    Graziadei, Ivo
    Schneeberger, Stefan
    Antretter, Herwig
    Mueller, Ludwig
    Zelger, Bettina
    Singh, Nina
    Pruett, Timothy L.
    Margreiter, Raimund
    Bonatti, Hugo
    TRANSPLANT INTERNATIONAL, 2008, 21 (06) : 534 - 546
  • [29] Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)
    Asgari, Maryam M.
    Arron, Sarah T.
    Warton, E. Margaret
    Quesenberry, Charles P., Jr.
    Weisshaar, Dana
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (03) : 444 - 450
  • [30] Enterovirus Infections in Solid Organ Transplant Recipients: a Clinical Comparison from a Regional University Hospital in the Netherlands
    Cassidy, Hayley
    van Leer-Buter, Coretta
    Niesters, Hubert G. M.
    MICROBIOLOGY SPECTRUM, 2022, 10 (01):